Literature DB >> 9628613

Disease progression following radical prostatectomy in men with Gleason score 7 tumor.

J I Epstein1, C R Pound, A W Partin, P C Walsh.   

Abstract

PURPOSE: The long-term prognosis of men with Gleason score 7 adenocarcinoma of the prostate is uncertain.
MATERIALS AND METHODS: We studied 488 men whose radical prostatectomy specimen showed Gleason score 7 tumor without involvement of the seminal vesicles or lymph nodes. Of the 400 men without progression 318 had been followed for 2 years or more and 93 for 7 years or more.
RESULTS: Cases of organ confined disease and negative margins regardless of extent of extraprostatic extension had roughly similar and better prognoses than cases of focal and established extraprostatic extension with positive margins. The greater influence of margin status on progression (p <0.0001) compared to extent of extraprostatic extension (p = 0.023) was evidenced in the multivariate analysis. Of 30 men with established extraprostatic extension and positive margins 6 (20%) had progression to distant metastases, which was similar to 14 of 58 (24%) without established extraprostatic extension and positive margins. There was no difference in response to radiotherapy between men with established extraprostatic extension and positive margins compared to the other cases.
CONCLUSIONS: Margins status greatly influences the risk of progression in men with Gleason score 7 tumors. Among men with Gleason score 7 tumors, except for those with established extraprostatic extension and positive margins, more than 50% appear to be cured at long-term followup. Because of the high risk of progression in patients with positive margins, clinical studies of adjuvant therapy in this population appear warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9628613

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

Authors:  Olivier Alenda; Guillaume Ploussard; Pascal Mouracade; Evanguelos Xylinas; Alexandre de la Taille; Yves Allory; Dimitri Vordos; Andras Hoznek; Claude Clement Abbou; Laurent Salomon
Journal:  World J Urol       Date:  2010-11-24       Impact factor: 4.226

2.  Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

Authors:  David E Kang; Nicholas J Fitzsimons; Joseph C Presti; Christopher J Kane; Martha K Terris; William J Aronson; Christopher L Amling; Stephen J Freedland
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

3.  Benign prostate glandular tissue at radical prostatectomy surgical margins.

Authors:  Anobel Y Odisho; Samuel L Washington; Maxwell V Meng; Janet E Cowan; Jeffry P Simko; Peter R Carroll
Journal:  Urology       Date:  2013-03-21       Impact factor: 2.649

Review 4.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

5.  Breast cancer clinical and translational research: analogies and implications for prostate cancer.

Authors:  Lea Baer; Silvia C Formenti
Journal:  Rev Urol       Date:  2007

Review 6.  PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer.

Authors:  Zheng Yang; Lu Yu; Zhe Wang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

7.  Management of high-risk localized prostate cancer.

Authors:  Ariel E Marciscano; Matthew E Hardee; Nicholas Sanfilippo
Journal:  Adv Urol       Date:  2011-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.